Toggle Nav
Close
  • Menu
  • Setting

Anti-ROR2 Antibody (Ozuriftamab vedotin)

Catalog No.
F1124
Anti-ROR2 Antibody (Ozuriftamab vedotin)
Grouped product items
SizePriceStock Qty
100ug
Please inquire
Ship with 3-5 days
1mg
Please inquire
Ship with 3-5 days
For scientific research use only and should not be used for diagnostic or medical purposes.

Tel: +1-832-696-8203

Email: [email protected]

Worldwide Distributors

Background

Ozuriftamab vedotin (BA 3021) is an antibody-drug conjugate (ADC) composed of ozuriftamab, aReceptor tyrosine kinase-like orphan receptor 2 (ROR2) A conditionally active biological (CAB) antibody, conjugated to monomethyl auristatin E, has potential antitumor activity.

Quality Control

Quality Control & DataSheet

View current batch:
 

M.Wt

150.25 kDa

Shipping

Dry ice

Cas No.

2460400-11-5

Storage

-80°C

Expiration Date

2 years

Form

Liquid

Concentration

See label

Reconstitution

For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.

Host

CHO

Alternative Names

CAB-ROR2- ADC, BA3021, BA 3021

Buffer System

100 mM Pro 20 mM Arg pH 5.0. No preservative!

Target Accession

Q01974

Reactivity

Human

Conjugation

MMAE

Clonality

Monoclonal

Purification

Protein A

Isotype

IgG1

Application

ELISA, FACS, Kinetics, Functional assay, Animal Model

Biological Activity

The drug-to-antibody ratio (DAR) of the Anti-ROR2 Antibody (Ozuriftamab vedotin) is 3.9.

Target

ROR2

Note

Please avoid freeze-thaw cycles.